NYSE:PBI | The Cinema Post
Tuesday , April 23 2019
Home / Tag Archives: NYSE:PBI

Tag Archives: NYSE:PBI

Oncolytics Biotech (NASDAQ:ONCY) Receives Authorization For Orphan Drug Designation- Pitney Bowes (NYSE:PBI), Agnico Eagle Mines (NYSE:AEM), Prologis (NYSE:PLD)

February 12, 2015 Business News Comments Off on Oncolytics Biotech (NASDAQ:ONCY) Receives Authorization For Orphan Drug Designation- Pitney Bowes (NYSE:PBI), Agnico Eagle Mines (NYSE:AEM), Prologis (NYSE:PLD)

A clinical-stage biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics, Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) reported that the U.S. Food and Drug Administration (FDA) has permitted Orphan Drug Designation for its lead product candidate, REOLYSIN, for the treatment of ovarian cancer. Whereas, shares of Oncolytics …

Read More »

News Roundup- Pitney Bowes (NYSE:PBI), CEL-SCI (NYSEMKT:CVM), Generex Biotechnology (OTCMKTS:GNBT), Lockheed Martin (NYSE:LMT)

October 22, 2014 Business News Comments Off on News Roundup- Pitney Bowes (NYSE:PBI), CEL-SCI (NYSEMKT:CVM), Generex Biotechnology (OTCMKTS:GNBT), Lockheed Martin (NYSE:LMT)

stocks

Pitney Bowes Inc. (NYSE:PBI) (Full FREE Analysis of PBI And Be Sure To Notice The Intermediate Period) reported that several recent actions in Europe have advanced its long-term strategy to grow client and shareholder value. The firm exited a non-core product line in Norway, transitioned to a dealer sales network …

Read More »
Powered by Thecinema Post | Designed by TCP Tech Team
© Copyright 2019, All Rights Reserved